JP Morgan Healthcare Conference Jan 11, 2022 JP Morgan Healthcare Conference Day 1: Qiagen, Adaptive Bio, Guardant Health, Natera, Sema4 Jan 14, 2021 JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More Jan 13, 2021 At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market Jan 13, 2021 JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 12, 2021 Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day One: Roche, Guardant, Hologic, Thermo Fisher, and More Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Jan 11, 2021 PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan Jan 16, 2020 JP Morgan Healthcare Day 4: Biocartis, Oxford Immunotec Jan 15, 2020 JP Morgan Healthcare Day 3: Natera, Exact Sciences, Accelerate Dx, GenMark, OraSure, Quidel, Invitae, Opko Jan 14, 2020 JP Morgan Healthcare Day 2: Abbott, Caris, Danaher, Quest, LabCorp, Luminex, Agilent, Adaptive Bio Jan 14, 2020 Illumina, Genomics England Ink Deal to Sequence up to 300K People Jan 13, 2020 JP Morgan Healthcare Day One: Qiagen, Guardant Health, Bio-Rad, Hologic, Myriad Genetics Jan 11, 2019 JP Morgan Healthcare, Day 4: OraSure, Meridian Bioscience, Biocartis, Veracyte Jan 10, 2019 JP Morgan Healthcare, Day 3: Quidel, Oxford Immunotec, Luminex, GenMark, Bio-Techne, and More Jan 10, 2019 Accelerate Diagnostics to Emphasize Outcomes Data as It Seeks Broader Adoption of Pheno System Jan 10, 2019 New Natera CEO Highlights Three Goals for Company at JP Morgan Jan 9, 2019 JP Morgan Healthcare, Day 2: Abbott, Quest, LabCorp, Exact Sciences, Guardant, Hologic, and More Jan 9, 2019 Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business Load More Breaking News BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Careviso Closes $17.4M Series B Funding Round P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test BioAffinity Technologies Nabs $15.6M from Public Offering
